Futuremeds Spain S.L. — Clinical Trial Site

48 Registered trials

30 Currently recruiting

Organisation

Futuremeds Spain S.L.

Location

Madrid, Spain

Identifier

ORG-100050324

Address

Glorieta De Mejico 1, 41012, Spain

Departments

#11102: Neurology
#40857: Medicina Interna
#724003:Neurología
#724007:Neurología
604: Reumatología
72405 Medicina Interna
72406 Medicina Interna
72407 Medicina Interna
Allergy
Cardiologia
Cardiology
Cardiology Department
Dept. of Rheumatology
Dermatology
Family Medicine
FutureMeds Spain Madrid
FutureMeds Spain Sevilla
Gastroenterology
Internal Medicine
Medicina de familia
Medicina Familia
Medicina Interna
N/A
Neumologia
Neuropediatric
Oncology
Pneumology
Reumatologia
Rheumatology
Servicio de Cardiologia
Servicio de Neurología

Clinical trials at this site (48)

Search interface

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants with Moderate-to-Severe Atopic Dermatitis (ADAPTIVE) Pending

2024-520117-50-00 Atopic Dermatitis 4
A Study to Investigate Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis (KATALYST-AV) Pending

2025-522176-86-01 Moderate Calcific Aortic Valve Stenosis (CAVS) 5
A study to evaluate the long-term safety, tolerability, and efficacy of subcutaneous sonelokimab in participants with psoriatic arthritis (P… Pending

2025-522471-28-00 psoriatic arthritis (PsA) 5
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Global Study with an Open-Label Extension to Evaluate the Efficacy and Safety of In… Pending

2025-523087-20-00 Duchenne muscular dystrophy 5
A study to learn if fenfluramine hydrochloride is safe and works in people with Rett syndrome Pending

2025-523157-34-00 Rett syndrome 5
Long-term safety and efficacy evaluation of lunsekimig (SAR443765) in adult participants with moderate-to-severe asthma. Recruiting

2025-522896-27-00 Asthma 4 2026-05-11
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria Recruiting

2025-522878-36-00 Chronic Spontaneous Urticaria 5 2026-04-20
A study to investigate efficacy, safety, immunogenicity, and pharmacokinetics of GSK3862995B following repeat doses in participants with bro… Recruiting

2025-522892-27-00 Bronchiectasis 4 2026-03-21
Randomised, Multicentre, Multinational, Double-Blind Integrated Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity … Recruiting

2025-521562-95-00 Previously Untreated Advanced (Unresectable or Metastat 5 2025-12-30
A Study to Learn About the Study Medicine Called Sigvotatug Vedotin in People with Locally Advanced, Unresectable, or Metastatic Non-Small C… Recruiting

2024-517968-36-00 non-small cell lung cancer 5 2025-07-08
Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight and Diabetes Recruiting

2025-523510-87-00 Obesity 5 2026-06-25
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer Recruiting

2025-522204-24-00 Drug-Related Side Effects and Adverse Reactions 4 2026-06-16
Efficacy and Safety of KAI-9531 in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes Recruiting

2025-523486-17-00 Obesity 5 2026-06-16
Long-Term Safety Study of Deucravacitinib versus Ustekinumab in Participants with Psoriasis (PRAGMATYK) Recruiting

2023-503766-24-00 Moderate to Severe Plaque Psoriasis 11 2026-05-26
Obicetrapib Versus Bempedoic Acid to Treat Dyslipidemia in Patients at High to Very High Cardiovascular Risk Recruiting

2025-524265-24-00 Dyslipidemia at High to Very High Cardiovascular Risk 5 2026-05-21
A clinical study of tulisokibart in people with psoriatic arthritis (MK-7240-015) Recruiting

2025-520997-21-00 Psoriatic arthritis 4 2026-05-08
EFFICACY AND SAFETY OF MET097 ONCE WEEKLY IN PEOPLE WITH OVERWEIGHT OR OBESITY AND TYPE 2 DIABETES (VESPER-5) Recruiting

2025-523975-48-00 Obesity 5 2026-05-08
Visugromab in Cachexia International Trial Recruiting

2025-523533-25-00 Cancer-associated Cachexia 10 2026-03-26
ZENITH: Zilebesiran in Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk … Recruiting

2025-522960-34-00 Established cardiovascular disease 5 2026-02-09
Efficacy and Safety of IMVT-1402 in Adult Participants with Primary Sjogren’s Disease with Moderate to Severe Systemic Disease Activity Recruiting

2025-520831-18-00 Primary Sjogren’s Disease 4 2025-12-12
A Phase 2 Randomized, Double-blind Placebo-Controlled Study to Evaluate the Pharmacokinetics, Immunogenicity, Safety and Efficacy of WIN378 … Recruiting

2025-521391-58-00 Asthma 4 2025-11-28
C4951063: A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine Recruiting

2024-517121-10-00 Menstrual Migraine 5 2025-10-17
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and … Recruiting

2024-516652-18-00 Atherosclerotic cardiovascular disease (ASCVD) and obes 5 2025-10-10
A study to investigate efficacy and safety of brivekimig in participants with Crohn’s disease Recruiting

2024-517016-30-00 Crohn’s disease 4 2025-09-26